Innograst 300mcg Injection

Innograst 300mcg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.

Innograst 300mcg Injection is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked to get regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine.

The most common side effects of this medicine include bone pain, weakness, headache, and rash. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, rash, sore throat, and swelling around the face or neck.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

• Prevention of Infections after chemotherapy

Prevention of Infections after chemotherapy
Innograst 300mcg Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Axokine

• Bone pain
• Weakness
• Headache
• Rash
• Nausea
• Increased lactate dehydrogenase level in blood
• Vomiting
• Increased uric acid level in blood
• Oropharyngeal pain
• Hair loss
• Fatigue
• Diarrhea
• Constipation
• Decreased appetite
• Cough
• Breathing problems
• Injection site reactions (pain, swelling, redness)

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Innograst 300mcg Injection is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections. .

• Innograst 300mcg Injection reduces the risk of infection in people treated with chemotherapy.
• It is usually given as a daily injection into the tissue just under the skin or into the vein.
• You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
• Store it in the refrigerator, protect it from light, and don't shake it.
• For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
• Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
• Use caution while driving or doing anything that requires concentration as Innograst 300mcg Injection may cause dizziness.
• Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
• Stop taking Innograst 300mcg Injection and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.

Kaushansky K, Kipps TJ. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1074-75.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 545-46.

Filgrastim. North Harrow, Middlesex: Accord Healthcare Limited; 2014 [revised 06 Feb. 2019]. [Accessed 24 Jan. 2019] (online) Available from:

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Filgrastim. [Updated 2019 Jun 3]. [Accessed 18 Feb. 2020] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from: